SRNE

Sorrento Therapeutics, Inc.
SRNE

Overview Fund Activity
Delisted

SRNE was delisted on the 22nd of February, 2023.

Back to rankings

229 hedge funds and large institutions have $640M invested in Sorrento Therapeutics, Inc. in 2021 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 71 increasing their positions, 67 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
229
Holders Change
+11
Holders Change %
+5.05%
% of All Funds
4.03%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
44
Increased
71
Reduced
67
Closed
31
Calls
$75.7M
Puts
$39.3M
Net Calls
+$36.5M
Net Calls Change
-$5.93M

Top Buyers

1
BlackRock
BlackRock
New York
+$14.8M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$10.3M
3
SM
Sabby Management
Florida
+$8.81M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$8.12M
5
Citadel Advisors
Citadel Advisors
Florida
+$4.31M

Top Sellers

1
State Street
State Street
Massachusetts
-$23.9M
2
CAM
Cormorant Asset Management
Massachusetts
-$14.5M
3
Goldman Sachs
Goldman Sachs
New York
-$10.4M
4
Morgan Stanley
Morgan Stanley
New York
-$9.45M
5
Jane Street
Jane Street
New York
-$7.23M
Name Holding Trade Value Shares
Change 		Shares
Change %
GWMIA
251
Global Wealth Management Investment Advisory
Florida
– -$2K -250 Closed
IWP
252
IAG Wealth Partners
Wisconsin
– -$2K -200 Closed
MSFP
253
Mark Sheptoff Financial Planning
Connecticut
– -$1K -200 Closed
AFS
254
Annapolis Financial Services
Maryland
– -$1K -100 Closed
7 8 9 10
11